Background Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …

Background Although some human studies have reported gut microbiome changes in
individuals with Alzheimer's disease (AD) dementia or mild cognitive impairment (MCI), gut …

Background Alzheimer's disease (AD) is a neurodegenerative disorder that causes gradual
memory loss. AD and its prodromal stage of mild cognitive impairment (MCI) are marked by …

Alzheimer's disease (AD) is the most common form of dementia. However, the
etiopathogenesis of this devastating disease is not fully understood. Recent studies in …

Numerous studies have described the notable impact of gut microbiota on the brain in
Alzheimer's disease (AD) via the gut–brain axis. However, the molecular mechanisms …

Background: Gut microbiota can influence human brain function and behavior. Recent
studies showed that gut microbiota might play an important role in the pathogenesis of …

Intimate metabolic host–microbiome crosstalk regulates immune, metabolic, and neuronal
response in health and disease, yet remains untapped for biomarkers or intervention for …

Gut microbiota is emerging as a key regulator of many disease conditions and its
dysregulation is implicated in the pathogenesis of several gastrointestinal and extraintestinal …

Background Plasma amyloid-β (Aβ) may facilitate identification of individuals with brain
amyloidosis. Gut microbial dysbiosis in Alzheimer's disease (AD) is increasingly being …

Background Microbiome-gut-brain axis may be involved in the progression of age-related
cognitive impairment and relevant brain structure changes, but evidence from large human …